In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Drugs currently available for patients with heart failure with preserved ejection fraction (HFpEF) have no mortality benefit, according to a meta-analysis published in…
NEW YORK (Reuters Health) – When patients with chronic obstructive pulmonary disease (COPD) come down with community-acquired pneumonia, whether or not they use inhaled corticosteroids has no effect…
NEW YORK (Reuters Health) – Eye drops containing lubricants, corticosteroids, cyclosporine, or autologous serum improve dry eye symptoms associated with Sjögren’s syndrome (SS), according to a literature review.…
Shlomo Maayan, MD, Director of the Hadassah AIDS Center, in Jerusalem, Israel, discusses the importance of taking a holistic approach to AIDS work in Africa. For more information…
Marilyn Mann, OD, of Comprehensive Eye Care in Valley Cottage, NY, interviews Terry Peterson, Senior Sales Executive for Carl Zeiss Meditec, regarding the Cirrus HD-OCT, the most advanced…
NEW YORK (Reuters Health) – Bosentan is not an effective therapy for patients with idiopathic pulmonary fibrosis (IPF), suggests a new study organized by the company that makes…
NEW YORK (Reuters Health) – Adding extra protein to enteral nutrition for critically ill children is safe and may help improve their protein metabolism, Spanish researchers report. Critically…
NEW YORK (Reuters Health) – There is no conclusive evidence that anti-arryhthmic drugs extend overall survival after cardiac arrest, the authors of a new research review conclude. These…
NEW YORK (Reuters Health) – The presence of low-frequency HIV-1 drug resistance mutations – especially against non-nucleoside reverse transcriptase inhibitors (NNRTIs) – confers a greater than twofold increased…
NEW YORK (Reuters Health) – In women with metastatic breast cancer, a longer duration of chemotherapy is associated with a clinically meaningful and statistically significant improvement in time…
